FDA approves UP-developed COVID-19 test kit

The Food and Drug Administration (FDA) has approved a COVID-19 testing kit developed by the University of the Philippines (UP) that can provide results in less than two hours.

Developed by Dr. Raul Destura and his team, the GenAmplify COVID-19 detection kit costs P1,320, significantly cheaper than imported testing kits.

The Department of Health (DOH) previously stated that the UP test kit may be rolled out on Monday, March 16.

However, FDA officer-in-charge Eric Domingo clarified that the UP-NIH 2019-nCov detection kits will not yet be available for public purchase by March 16.

Field testing will be conducted to determine the validity of results, with specimens compared against findings from the Research Institute for Tropical Medicine and confirmed by gene sequencing at the Philippine Genome Center.

The FDA has approved the UP test kit, but it requires emergency use listing with the World Health Organization before it can be rolled out.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.